Skip to main content

Are you Dr. Li?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 63 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    904 7th Ave
    Seattle, WA 98104
    Phone+1 206-329-1760

Summary

  • Dr. Henry Li, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is affiliated with Swedish Cherry Hill Campus, Seattle VA Medical Center, and MultiCare Tacoma General Hospital.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1999 - 2002
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 1996 - 1999
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 1996

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1998 - 2026
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
  • Top MD Consumers Checkbook

Publications & Presentations

PubMed

Press Mentions

  • CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models
    CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) ModelsSeptember 27th, 2018
  • CARsgen Therapeutics and CrownBio Complete CAR-T Study for Gastric Cancer
    CARsgen Therapeutics and CrownBio Complete CAR-T Study for Gastric CancerSeptember 13th, 2018
  • CrownBio Expands Genetically Engineered Model Selection via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
    CrownBio Expands Genetically Engineered Model Selection via Strategic Alliance with Shanghai Model Organisms Center (SMOC)August 14th, 2018